Suvizumab: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 57: | Line 57: | ||
{{monoclonal-antibody-stub}} | {{monoclonal-antibody-stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Revision as of 18:11, 10 February 2025
| Suvizumab | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 914257-21-9 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.<ref>,
Proposed List number 102 of International Nonproprietary Names, WHO Drug Information, 2009, Vol. 23(Issue: 4), Full text,</ref>
References
<references/>
| Monoclonal antibodies for infectious disease and toxins |
|---|
|
This article is a antiinfective drug stub. You can help WikiMD by expanding it!
This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!
